Table 3 Demographics, clinical and tumor characteristics at diagnosis, surgical data, and oncological outcomes for women 18–40 years old who either had or had not given birth after undergoing FSS for epithelial ovarian cancer in Sweden 2008–2015
Given Birth After FSS | Not Given Birth After FSS | P-value | |
|---|---|---|---|
N (%) | 9 (25) | 27 (75) | |
Mean age, years (range) | 28 (23–37) | 29 (19–39) | 0.626 |
Previous parity, n (%) | |||
0 | 5 (56) | 22 (81) | 0.133 |
1 | 3 (33) | 3 (11) | |
2 | 1 (11) | 1 (4) | |
≥ 3 | 0 | 0 | |
FIGO stage, n (%) | |||
IA | 5 (56) | 22 (81) | 0.184 |
IB | – | – | |
IC | 4 (44) | 5 (19) | |
IC1 | 4 | 2 | |
IC2 | 3 | ||
IC3 | – | – | |
Histologic type, n (%) | |||
Serous, high-grade | 2 (7) | ||
Serous, low-grade | 1 (11) | ||
Mucinous | 4 (44) | 14 (52) | |
Endometrioid | 4 (44) | 6 (22) | |
Grade 1 | 3 | 3 | |
Grade 2 | 2 | ||
Grade 3 | 1 | – | |
Clear cell | 0 | 3 | |
Other a | 0 | 2 | |
Surgical mode,b n (%) | |||
Open | 6 (67) | 21 (78) | 0.335 |
Laparoscopy | 3 (33) | 3 (11) | |
Robot | 0 | 3 (11) | |
Type of surgery, n (%) | |||
Primary | 4 (44) | 13 (48) | |
Re-staging | 5 (56) | 14 (52) | |
Type of staging procedure, n (%) | |||
Cytology | 8 (89) | 22 (82) | |
Peritoneal biopsies | 9 (100) | 27 (100) | |
Oment | 6 (67) | 20 (74) | |
LN pelvic | 1 (11) | 2 (7) | |
LN paraaortic | 1 (11) | 3 (11) | |
Adjuvant chemotherapy, n (%) | 4 (44) | 9 (33) | 0.693 |
Histologic review,c n (%) | 8 (89) | 25 (93) | 1.00 |
Recurrence, n (%) | 0 | 2 (7) | |
Died of disease, n (%) | 0 | 1 (4) | |
Follow-up, months, mean (range) | 75 (44–111) | 56 (16–99) | 0.04 |